Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LAZURE: AZD0780 + Rosuvastatin in Dyslipidaemia
NCT07218900Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2025
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of laroprovstat in dyslipidemia, sponsored by AstraZeneca. Started Nov 2025; status: completed.
02
Drugs
laroprovstat
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT07218900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07218900.